Pharmafile Logo

Navigating the rapidly changing oncology treatment landscape: how digital tools can help

With rapid growth comes growing pains…

- PMLiVE

The field of oncology is rapidly growing and evolving. In 2022, global spending on cancer medicines was approximately 196 billion USD, and this number is forecasted to reach $375 billion by 2027. In fact, for the past five years, the number of treated patients with cancer has seen an average annual increase of 5% globally (1). However, with rapid growth comes growing pains.

Specific challenges facing the oncology field

1. Increased competition and evolving standard of care

New competitors are entering the market at a rapid pace, and competition is intensifying. There are currently more than 2,000 oncology products under development. Emerging biopharma companies are responsible for over 70% of these products (up 20 percentage points from 2017) while Big Pharma has seen a declining share of the oncology pipeline, at only around 20% of products currently under development (down 15 percentage points from 2017). This competitive intensity tends to focus on smaller patient populations with multiple treatment options.

With a larger number of treatable patients, improving survival rates, more clinical trials, and increased focus on real-world evidence, the definition of ‘standard of care’ is continuously changing. As a result, treatment algorithms are becoming more complex, leading to variable uptake and use of new treatments across regions, clinics, and prescribers.

Further, the time advantage traditionally afforded to new cancer therapies has been substantially reduced due to advances in our understanding of the underlying tumor biology and the emergence of novel treatment modalities. Occasionally, the advantage disappears well before the period of exclusivity ends (2)…

Read the full article here.

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Accelerating Digital Health Innovation Success

Fard Johnmar, Founder of Enspektos, and Denise Pines, President of the Medical Board of California, discuss the concepts of “FemAging” and “ePatients”, and how COVID-19 has affected both of these. We explore an...

Courageous Conversation ep.9: Elon Musk’s Neuralink and the Future of the Computer Brain Interface

Natalie Yeadon, Co-Owner and Managing Director at Impetus Digital, provides insight on Elon Musk's Neuralink and the Future of the Computer Brain Interface.

Ongoing Virtual Communication between MSLs and Physicians: a Customer Story

Learn how one of our clients used the Impetus InSite Platform to connect their MSLs with regional groups of physicians.

Using Artificial Intelligence to Transform Pharma

Dr. Andree Bates, Founder & CEO of Eularis, discusses how Eularis helps healthcare teams utilize AI and “Future Tech” to solve their biggest commercial challenges and deliver measurable growth. Among many...

Transforming Unstructured Healthcare Information into Real-World Evidence & Life Saving Insights

Aaron Leibtag, CEO & Co-Founder of Pentavere Research Group, discusses his transition from being an Organizational Transformation Leader to co-founding a startup focused on healthcare technology. We also dive into how...

InSite Mapping™ – a Novel Tool for Insight-gathering and Patient Journey Mapping

Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE.

Building Stakeholder Relationships in the New Normal

Randi Goeckeler, Global Stakeholder Relations & Strategic Engagement Leadership Expert, discusses some of the key lessons she has learned from the various roles she has held at top pharma companies....

Personalized Digital Health Coaching

Eugene Borukhovich, Chairman & COO of YourCoach.Health, discusses his transition from Global Head of Digital Health at Bayer to full-time entrepreneur. We also talk about YourCoach’s mission, the impact of COVID-19...

Empowering Medtech Innovation

Scott Phillips, President at StarFish Medical, shares his ongoing work to empower MedTech innovation in Canada and overseas. We also discuss how COVID-19 has impacted the MedTech industry and the many...